Page last updated: 2024-08-18

pyrroles and Acute Relapsing Multiple Sclerosis

pyrroles has been researched along with Acute Relapsing Multiple Sclerosis in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	8 (66.67)	29.6817
2010's	4 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burren, Y; Donati, F; El-Koussy, M; Findling, O; Humpert, S; Kamm, CP; Kappos, L; Mattle, HP; Müller, F; Müller, M; Naegelin, Y; Schwegler, G; Slotboom, J	1
Jiang, H; Li, XL; Wang, MX; Yan, X; Yu, CM; Zhang, B; Zhang, WJ; Zhang, ZC	1
Altafullah, I; Birnbaum, G; Cree, B; Reder, AT; Zinser, M	1
Greeve, I; Mattle, HP; Sellner, J	1
Altafullah, I; Birnbaum, G; Cree, B; Morra, VB; Orefice, G; Reder, A; Salvatore, E	1
Kamm, CP; Mattle, HP	1
Brescia Morra, V; Brunetti, A; Carotenuto, B; Lanzillo, R; Lus, G; Orefice, G; Prinster, A; Quarantelli, M; Rinaldi, C; Salvatore, E; Spitaleri, D; Tedeschi, G; Vacca, G; Ventrella, G	1
Burren, Y; Donati, F; El-Koussy, M; Findling, O; Goebels, N; Humpert, S; Kamm, CP; Kappos, L; Mattle, HP; Müller, F; Müller, M; Naegelin, Y; Schött, D; Schwegler, G; Slotboom, J; Tettenborn, B; von Bredow, F	1
Antel, J; Arnold, DL; Bar-Or, A; Bodner, CA; Campagnolo, D; Garren, H; Gianettoni, J; Jalili, F; Kachuck, N; Lapierre, Y; Niino, M; Oger, J; Price, M; Rhodes, S; Robinson, WH; Shi, FD; Steinman, L; Utz, PJ; Valone, F; Vollmer, T; Weiner, L	1
Findling, O; Grandgirard, D; Greeve, I; Leib, SL; Mattle, HP; Sellner, J	1
Aktas, O; Bellmann-Strobl, J; Dörr, J; Haertle, M; Paul, F; Volk, HD; Waiczies, H; Waiczies, S; Wernecke, KD; Wuerfel, J; Zipp, F	1
Greeve, I; Leib, SL; Mattle, HP; Sellner, J	1

Trials

11 trial(s) available for pyrroles and Acute Relapsing Multiple Sclerosis

Article	Year
Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial. PloS one, 2014, Volume: 9, Issue:1 Topics: Adjuvants, Immunologic; Adult; Atorvastatin; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Interferon beta-1b; Interferon-beta; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pyrroles; Single-Blind Method; Treatment Outcome; Young Adult	2014
Atorvastatin calcium in combination with methylprednisolone for the treatment of multiple sclerosis relapse. International immunopharmacology, 2014, Volume: 23, Issue:2 Topics: Administration, Oral; Adult; Atorvastatin; Brain; Cytokines; Drug Administration Schedule; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis, Relapsing-Remitting; Pyrroles; Spinal Cord; Treatment Outcome	2014
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology, 2008, Oct-28, Volume: 71, Issue:18 Topics: Adult; Analysis of Variance; Atorvastatin; Chi-Square Distribution; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Interferon-beta; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neurologic Examination; Pyrroles; Survival Analysis	2008
Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2008, Volume: 14, Issue:7 Topics: Adjuvants, Immunologic; Adolescent; Adult; Atorvastatin; Biomarkers; C-Reactive Protein; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon beta-1b; Interferon-beta; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pyrroles	2008
SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology. Trials, 2009, Dec-14, Volume: 10 Topics: Adjuvants, Immunologic; Anticholesteremic Agents; Atorvastatin; Drug Therapy, Combination; Heptanoic Acids; Humans; Interferon beta-1b; Interferon-beta; Multiple Sclerosis, Relapsing-Remitting; Pyrroles; Secondary Prevention; Switzerland	2009
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. Multiple sclerosis (Houndmills, Basingstoke, England), 2010, Volume: 16, Issue:4 Topics: Adult; Anti-Inflammatory Agents; Atorvastatin; Chi-Square Distribution; Contrast Media; Disability Evaluation; Drug Administration Schedule; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Interferon beta-1a; Interferon-beta; Longitudinal Studies; Magnetic Resonance Imaging; Male; Multiple Sclerosis, Relapsing-Remitting; Predictive Value of Tests; Pyrroles; Severity of Illness Index; Statistics, Nonparametric; Time Factors; Treatment Outcome	2010
Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial. Journal of neurology, 2012, Volume: 259, Issue:11 Topics: Adolescent; Adult; Atorvastatin; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Interferon beta-1b; Interferon-beta; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Pyrroles; Single-Blind Method; Treatment Outcome; Young Adult	2012
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Archives of neurology, 2007, Volume: 64, Issue:10 Topics: Adult; Atorvastatin; Disability Evaluation; Double-Blind Method; Endpoint Determination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immune Tolerance; Immunization; Injections, Intramuscular; Lymphocyte Count; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Myelin Basic Protein; Oligonucleotide Array Sequence Analysis; Plasmids; Pyrroles; Recurrence; T-Lymphocytes; Vaccines, DNA	2007
Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis. Clinical and experimental immunology, 2008, Volume: 152, Issue:2 Topics: Adolescent; Adult; Atorvastatin; Drug Therapy, Combination; Fas Ligand Protein; fas Receptor; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon beta-1b; Interferon-beta; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Pyrroles; Solubility; Treatment Outcome	2008
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. PloS one, 2008, Apr-09, Volume: 3, Issue:4 Topics: Adjuvants, Immunologic; Administration, Oral; Atorvastatin; Gadolinium; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-beta; Interleukins; Magnetic Resonance Imaging; Models, Biological; Multiple Sclerosis, Relapsing-Remitting; Multivariate Analysis; Pyrroles; Recurrence; Treatment Outcome	2008
Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis. Archives of neurology, 2008, Volume: 65, Issue:5 Topics: Adjuvants, Immunologic; Adult; Atorvastatin; Biomarkers; Central Nervous System; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Interferon beta-1b; Interferon-beta; Matrix Metalloproteinase 9; Multiple Sclerosis, Relapsing-Remitting; Pyrroles; Tissue Inhibitor of Metalloproteinase-1; Treatment Outcome	2008

Other Studies

1 other study(ies) available for pyrroles and Acute Relapsing Multiple Sclerosis

Article	Year
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. Neurology, 2009, Sep-29, Volume: 73, Issue:13 Topics: Adjuvants, Immunologic; Atorvastatin; Disease Progression; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon beta-1a; Interferon-beta; Multiple Sclerosis, Relapsing-Remitting; Pyrroles	2009